Recent Developments in Health Economic Modelling of Cancer Therapies
Arguably, the most common structure currently adopted for oncology modelling is the three-state partitioned survival model with the following states: stable disease, post-progression and dead. This design can, therefore, be adopted to capture the progressive nature of cancer. This chapter outlines the three-state model approach as well as introducing several other key aspects of economic modelling in oncology.
KeywordsHealth economic modelling Survival model Quality-adjusted life year Utilities
- Davis S (2014) Assessing technologies that are not cost-effective at a zero price. Report by the NICE Decision Support Unit. University of SheffieldGoogle Scholar
- Latimer N (2013). Nice DSU Technical Support Document. Survival analysis for economic evaluations alongside clinical trials–extrapolation with patient-level dataGoogle Scholar
- NICE (2013) Guide to the methods of technology appraisal, London, UKGoogle Scholar
- NICE (2009) Appraising life-extending, end of life treatments. National Institute for Health and Care Excellence. Available from: http://www.nice.org.uk/guidance/gid-tag387/resources/appraising-life-extending-end-of-life-treatments-paper2
- Woods B, Sideris E, Palmer S et al (2017) NICE DSU technical support document 19: partitioned survival analysis for decision modelling in health care—a critical review, Sheffield, UKGoogle Scholar